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ABSTRACT
A DNA ligase IV (LIG4)-null human pre-B cell line
and human cell lines with hypomorphic mutations
in LIG4 are signi®cantly impaired in the frequency
and ®delity of end joining using an in vivo plasmid
assay. Analysis of the null line demonstrates the
existence of an error-prone DNA ligase IV-independ-
ent rejoining mechanism in mammalian cells.
Analysis of lines with hypomorphic mutations
demonstrates that residual DNA ligase IV activity,
which is suf®cient to promote ef®cient end joining,
nevertheless can result in decreased ®delity of
rejoining. Thus, DNA ligase IV is an important factor
in¯uencing the ®delity of end joining in vivo. The
LIG4-defective cell lines also showed impaired end
joining in an in vitro assay using cell-free extracts.
Elevated degradation of the terminal nucleotide was
observed in a LIG4-defective line, and addition of
the DNA ligase IV±XRCC4 complex restored end
protection. End protection by DNA ligase IV was not
dependent upon ligation. Finally, using puri®ed
proteins, we demonstrate that DNA ligase IV±XRCC4
is able to protect DNA ends from degradation by T7
exonuclease. Thus, the ability of DNA ligase
IV±XRCC4 to protect DNA ends may contribute to
the ability of DNA ligase IV to promote accurate
rejoining in vivo.
INTRODUCTION
DNA non-homologous end joining (NHEJ) represents the
major mechanism for the repair of DNA double-strand breaks
(DSBs) in mammalian cells and also effects rearrangements at
the site-speci®c DSBs introduced during V(D)J recombination
(1). Five proteins that function in NHEJ in mammalian cells
have been identi®ed to date (2). The heterodimeric Ku protein,
comprising subunits Ku70 and Ku80, binds strongly to
double-stranded DNA (ds DNA) ends. When DNA bound,
Ku recruits the DNA-dependent protein kinase catalytic
subunit (DNA-PKcs) and thereby activates its kinase activity.
Ku and DNA-PKcs together constitute the DNA-PK complex
(3,4). An additional complex of DNA ligase IV and Xrcc4 (the
DNA ligase IV±XRCC4 complex) is also required for NHEJ
(1,2). Recently, a further protein, Artemis, was also shown to
have some involvement in NHEJ (5). Mutants lacking these
components show pronounced radiosensitivity, defective
ability to repair DNA DSBs and impaired V(D)J recombina-
tion. Recently, hypomorphic mutations in DNA ligase IV were
identi®ed in some human patients displaying immuno-
de®ciency and developmental delay (6).
Although NHEJ was ®rst identi®ed in mammalian cells, the
process is also conserved in lower eukaryotes. However,
whilst NHEJ is the major mechanism for the repair of DSBs in
higher organisms, its contribution to overall DSB repair in
yeast may be restricted to situations in which homologous
recombination (HR) cannot function (7,8). HR is an ef®cient
and accurate DSB rejoining process since any information lost
at the break site is retrieved using the undamaged template.
Currently, little is known about the level of accuracy achieved
by NHEJ.
The characterization of NHEJ in yeast has relied upon an
in vivo plasmid end-joining assay in which the repair of DSBs
generated by restriction enzymes is examined using plasmids
that lack homology with chromosomal sequences. A dramatic
defect in plasmid rejoining is seen in NHEJ-defective yeast
strains (9±11). This assay has proved an important tool to
examine both the ef®ciency and ®delity of the rejoining
process.
A plasmid-based assay has been widely used to characterize
the process of V(D)J recombination in mammalian cells. It has
been shown to be dependent upon the known NHEJ
components and re¯ects events that occur at the endogenous
loci (12±14). In contrast, the use of an in vivo plasmid assay to
examine DSB rejoining in rodent cell lines lacking NHEJ
components failed to demonstrate any signi®cant defect
(15±17). The plasmid-based host cell end-joining assay has
also been used in human cells to examine the ®delity of DSB
rejoining (18±22). However, to date, it is unclear whether
plasmid rejoining in human cells re¯ects a process controlled
by the known NHEJ components (Ku, DNA-PKcs, Xrcc4 and
DNA ligase IV).
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In this study, we show that a LIG4-null human pre-B cell
line as well as cell lines derived from LIG4 syndrome patients
are markedly impaired in in vivo plasmid end joining,
demonstrating that the assay monitors NHEJ. The residual
end joining observed in LIG4-null cells demonstrates the
presence of an error-prone DNA ligase IV-independent end-
joining process in mammalian cells. Additionally, one cell line
with a hypomorphic mutation in DNA ligase IV retained
suf®cient DNA ligase IV activity to promote substantial
rejoining, but the ®delity of rejoining was markedly impaired.
Thus, in human cells, DNA ligase IV is an important factor
in¯uencing the ®delity of rejoining in vivo. An examination of
end joining in vitro using cell-free extracts from LIG4-
defective cell lines shows that the presence of DNA ligase IV
can serve to protect the ends from DNA degradation as well as
to rejoin them.We also show that the presence of DNA ligase
IV±XRCC4 alone or in combination with Ku contributes to the
protection of DNA ends from degradation by T7 exonuclease
even in the absence of ligation. The ability of DNA ligase
IV±XRCC4 to restrict degradation of DNA ends may
contribute towards its ability to promote accurate rejoining
in vivo.
MATERIALS AND METHODS
Cell culture
The N114P2 cells and the parental cell line, Nalm-6, isolated
as described previously (23), were cultured in RPMI 1640
medium supplemented with 10% fetal calf serum (FCS),
L-glutamine and penicillin/streptomcyin. 180BR primary and
180BRneo transformed ®broblasts were cultured as previously
described (24). 1BR3 and 1BR3neo are a normal primary and
immortalized ®broblast cell line, respectively, used as con-
trols. Fibroblasts were cultured in minimal essential medium
supplemented with 15% FCS, penicillin and streptomycin as
described previously. LB2304 lymphoblastoid cells were
obtained as described previously (6). AHH1, a lymphoblastoid
cell line derived from a healthy donor, was used as a control
(25). Lymphoblasts were grown in suspension in RPMI 1640
medium supplemented with glutamine (2 mM), gentamycin
(40 mg/ml) and 10% (v/v) FCS.
N114P2 cells express normal levels of XRCC4 as visualized
by immuno¯uorescence (data not shown). The R278H muta-
tion in 180BR cells results in a 80±90% decrease in protein
activity, but XRCC4 and DNA ligase IV are expressed
normally (26). The LB2304 cell line has barely detectable
levels of DNA ligase IV but normal levels of XRCC4 (6; data
not shown).
Host cell end-joining assay
The recombination substrate pHRecCJ (18,27) or its modi®ed
derivatives, pHRrecCJV or pHRecCJI (see Fig. 1), were
linearized by digestion with either EcoRV or EcoRI (Promega)
to generate blunt-ended breaks or cohesive-ended breaks with
5¢ overhangs, respectively. For the substrates pHRecCJV or
pHRecCJI, linear molecules were separated from the excized
fragment and any uncut molecules by agarose gel electro-
phoresis. Exponentially growing cells were transfected with
1.25±2 mg of linearized plasmid DNA by electroporation
(lymphoblastoid cell lines) as described previously (18,27) or
by Ca3(PO4)2 (®broblast cell lines). The pre-B cells were
transfected using an Easyject Plus Electroporator (Flowgen,
Lich®eld, UK). Parallel transfections were carried out using an
equivalent quantity of circular plasmid molecules. Cells were
harvested 48 h after transfection, lysed and plasmid DNA
extracted using a modi®cation of the Qiagen miniprep
protocol. Since linearized plasmids have to be recircularized
in order to replicate in human cells, recovered DNA samples
were digested with the restriction enzyme DpnI, which
recognizes and cuts only bacterially methylated GATC
sequences (dam+). Thus, the DpnI digestion ensures that
only plasmids repaired and replicated in human cells will be
recovered. Routinely, one-half of the mini-lysis was digested
with DpnI but, in experiments where the plasmid recovery was
low, as much of the mini-lysis as possible was used for DpnI
digestion and subsequent analysis. The DpnI-digested DNA
was electroporated into bacteria, XL1-blue or DH5a, and
colonies carrying the plasmids were selected on LB plates
containing 100 mg/ml ampicillin. Colonies were counted
following appropriate dilution, and the numbers given in
Table 1 represent those estimated to be present in the 1 ml used
for transformation. End-joining frequency was estimated from
the number of colonies obtained after transformation with
linear versus circular plasmids.
Analysis of rejoined plasmids
To assess the accuracy of rejoining, DNA from the plasmids
was digested with the restriction enzyme used to generate the
DSB. Those events that had not restored the original
restriction site (i.e. inaccurate repair events) were analyzed
by further restriction analysis and DNA sequencing. Only
DNA sequence analysis has been described here. Statistical
analysis of data was performed using either the Student t-test
or the c2 test with Yates' correction. The P-values for the test
are indicated when appropriate.
Immunoblotting
Whole-cell extracts were prepared as previously described
(28). The anti-DNA ligase IV antibody was raised against the
whole protein.
Preparation of cellular extracts
Extracts were prepared according to the protocol of Baumann
and West (29). Brie¯y, 1±2 3 109 cells were harvested,
washed three times with phosphate-buffered saline and once
with hypotonic lysis buffer [10 mM Tris±HCl pH 8.0, 1 mM
EDTA, 5 mM dithiothreitol (DTT)]. Cells were resuspended
in 2 vol of hypotonic buffer, incubated on ice for 20 min and
then lysed by homogenization while progressively adding the
protease inhibitors (phenylmethylsulfonyl ¯uoride 0.17 mg/
ml; aprotinin, 0.01 U/ml trypsin inhibitor; and 1 mg/ml each of
pepstatin, chymostatin and leupeptin). After 20 min on ice,
0.5 vol of high salt buffer (50 mM Tris±HCl pH 7.5, 1 M KCl,
2 mM EDTA, 2 mM DTT) was added and the extract was
centrifuged for 3 h at 42 000 r.p.m. in a Beckman SW50.1
rotor. The supernatant was recovered and dialyzed for 3 h
against E buffer [20 mM Tris±HCl pH 8.0, 0.1 M KOAc, 20%
(v/v) glycerol, 0.5 mM EDTA, 1 mM DTT]. Aliquots were
fast frozen and stored at ±80°C.
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In vitro end-joining reactions
End-joining reactions were performed with the plasmid pSJ
(3.3 kb), a derivative of pHRecSJ (22). The plasmid was
linearized with SalI (New England Biolabs) to create cohesive
termini with 5¢ overhangs. To generate a non-ligatable
substrate, a single nucleotide (dTTP) was incorporated using
DNA polymerase I large Klenow fragment (New England
Biolabs). These plasmids were subsequently subjected to
DNA ligation (T4 DNA ligase, New England Biolabs). Linear
molecules, i.e those resistant to ligation due to the incorpor-
ation of a single nucleotide, were isolated by gel electrophor-
esis and used as a substrate for ligation. To analyze end
degradation, the substrate was dephosphorylated and 5¢-end
labeled with [g-32P]ATP (ICN, France) using T4 polynucle-
otide kinase (New England Biolabs). Reactions (15 ml) were
carried out in 50 mM Tris±HCl pH 7.5, 0.5 mM Mg(OAc)2,
60 mM KOAc, 1 mM ATP, 1 mM DTT, 100 mg/ml bovine
serum albumin and 20 ng of linearized plasmid. Incubation
was for 2 h at 37°C. DNA products were deproteinized,
separated by electrophoresis through a 0.8% agarose gels and
visualized either directly by autoradiography (5¢-32P-labeled
DNA) or by Southern transfer and hybridization with a 0.8 kb
fragment from the LacZ gene, radioactively labeled with
[a-32P]dCTP (ICN, France) by random priming (Rediprime II
kit, Amersham Pharmacia Biotech, France). The ligase
IV±XRCC4 complex and Ku were expressed in insect cells
and prepared as described previously (26). The reaction
products were quanti®ed with a Storm phosphorimager
(Molecular Dynamics).
Protection of DNA ends by the DNA ligase IV±XRCC4
complex and Ku
The cohesive- and blunt-ended fragments were produced from
Bluescript using A¯II±PstI- or PvuII-generating fragments,
respectively. A 20 ng aliquot of end-labeled fragment was pre-
incubated with the indicated amounts of DNA ligase
IV±XRCC4 and/or Ku 70/80 for 30 min on ice in the reaction
mixture described previously (26). T7 exonuclease (5 U; New
England Biolab), the minimum amount that gave nearly
complete digestion, was added and the reactions were
incubated at room temperature for another 30 min. After
incubation, reactions were deproteinized, phenol/chloroform
extracted and precipitated. Aliquotes were run on 0.8%
agarose gels. Dried gels were analyzed and quanti®ed using
a STORM phosphorimager (Molecular Dynamics).
RESULTS
The frequency and ®delity of plasmid DNA end joining
in vivo are dramatically impaired in a LIG4-null cell line
A human pre-B cell line, N114P2, with targeted disruptions in
both LIG4 alleles, and its parental line, Nalm-6, were used to
examine the requirement for DNA ligase IV in a plasmid-
based host cell end-joining assay. The experimental approach
is similar to that previously described (18,19,22). The
plasmids used are based on pHRecCJ and are able to replicate
in human cells and in Escherichia coli. For the experiments
with pre-B cells, modi®ed pHRecCJ substrates (pHRecCJV
and pHRecCJI) were used, which enable uncut plasmids to be
distinguished from accurately rejoined molecules (Fig. 1). The
plasmids were linearized using EcoRV or EcoRI to create
blunt or 5¢-complementary ends, respectively, and transfected
into the human cell lines. Parallel experiments were carried
out using uncut circular plasmid molecules. After 48 h,
plasmids were recovered and digested with DpnI, a methyla-
tion-speci®c restriction enzyme. Since mammalian cells do
not methylate DpnI sites following replication, plasmids that
have failed to be repaired and replicate within the human cells
are eliminated. After transfection into bacteria, the proportion
of colonies recovered using cut plasmid relative to uncut
plasmid was taken to represent the end-joining frequency.
The end-joining frequency for both EcoRV- and EcoRI-
generated DSBs was markedly lower in the LIG4±/± N114P2
cells relative to the parental, Nalm-6 cells (Table 1). For
EcoRV-cut plasmids, the decrease was >100-fold, with a more
modest decrease (~14-fold) for EcoRI-cut plasmids. Although
we observed considerable inter-experimental variation in end-
joining frequency, the defect in the LIG4-null line (N114P2)
was reproducible and non-overlapping with the control range.
To verify that the decreased end-joining frequency is due to
the lack of DNA ligase IV, plasmid expressing LIG4 cDNA
was transfected together with EcoRV-cut plasmid. Although
the frequency did not reach that found in the Nalm-6 cells,
signi®cantly increased end joining was observed in the
presence of LIG4 cDNA, showing that the impaired end-
joining frequency in N114P2 cells is a direct consequence of
the targeted disruptions in LIG4 (Table 1, experiment 3). The
lack of full complementation is most likely explained by the
fact that this is a transient transfection system involving co-
transfection of two plasmids. It is also possible that DNA
ligase IV is not fully expressed in the transfected cells.
To assess the accuracy of rejoining, recovered plasmids
were digested with the restriction enzyme used for lineariza-
tion (EcoRI or EcoRV). Due to the low recovery of
recombinants obtained for N114P2 cells in the above experi-
ments, several additional transfections were carried out to
increase the number of recombinants available for analysis.
The analysis of plasmids obtained following transfection of
Figure 1. The substrate pHRecCJ and modi®cations, pHRecCJI and
pHRecCJV. All plasmids contain the prokaryotic ColE1 origin, the
b-lactamase gene (AmpR), the SV40 origin of replication and large
T-antigen-coding sequence. In the original substrate, pHRecCJ, the target
LacZ gene is interrupted by an intervening sequence that includes the
unique restriction sites EcoRI and EcoRV. The two modi®ed pHRecCJ
substrates, pHRecCJI and pHRecCJV, contain two closely located EcoRI or
EcoRV restriction sites that have been generated by the insertion of a
fragment at the unique EcoRI or EcoRV site of pHRecCJ.
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N114P2 cells with EcoRV-linearized substrates indicates that
none of the 130 recombinants had been rejoined accurately
(Table 2). However, a similar low level of accurate repair (2%)
was observed with control Nalm-6 cells (Table 2). For
transfections involving EcoRI-restricted plasmids, N114P2
cells displayed a sign®cantly lower level of accurate repair
compared with the control Nalm-6 cells (4% versus 22%,
P <0.0001) (Table 2).
To characterize the recovered recombinants further, a
sample of inaccurately rejoined plasmids was examined by
sequencing (Table 2). Among the plasmids recovered from
Nalm-6 and N114P2 cells, a similar range of deletion sizes
was observed for both EcoRV- and EcoRI-cut substrates
(1±1364 and 1±909 bp, respectively). The small increase in
mean deletion size seen in N114P2 cells (Table 2) was not
considered to be signi®cant considering the wide range in
deletion sizes. Sequencing also exposed further features of the
junctions, namely the presence of insertions and direct repeat
sequences. The presence of microhomology at the junctions
can only be assessed accurately in those plasmids that did not
have insertions. For both cell lines, microhomology was
observed at the majority of the inaccurately rejoined junctions
not associated with insertions (Table 2). A striking feature was
the presence of insertions at many of the Nalm-6 junctions (61
and 85% for EcoRV and EcoRI, respectively) (Table 2). In
Nalm-6 cells, these insertions, which were short (1±10 nt) and
had a high GC content, strongly resemble N (non-templated)
nucleotide insertions generated during V(D)J recombination
by terminal deoxynucleotidyl transferase (TdT) (28). Nalm-6
cells express high levels of TdT (data not shown) and insert
TdT nucleotides in vivo during V(D)J recombination (12). Our
data suggest that TdT can also add nucleotides during end
Table 1. End-joining frequency in Lig4±/± cells
Cell line Exp EcoRV-restricted plasmid EcoRI-restricted plasmid
Coloniesd % EJ Lig4+/+/Lig4±/± Coloniesd % EJ Lig4+/+/Lig4±/±
(cut/uncut) (cut/uncut)
Nalm-6 (Lig4+/+) 1 43/1411c 3.0 6880/49 920c 13.7
2 1.07 3 105/2.3 3 107c 0.4 2.4 3 105/1.2 3 107b 2.0
3 940/14 000a 6.7
N114P2 (Lig4±/±) 1 0/5547c <0.018 >167.0 860/1.1 3 105c 0.8 17.1
2 3/1.3 3 106b ~0.0002 ~2000.0 24 186/1.5 3 107b 0.16 12.5
3 80/1.7 3 105a 0.047 143.0
N114P2+pcDNA3 3 300/1.7 3 105a 0.18 37.0
N114P2+pcDNA3/Lig4 3 2540/1.7 3 105a 1.5 4.5
a±cThe number of replicate transfections carried out in each experiment, with a, b and c representing 1, 2 and 3 replicated experiments, respectively.
dColonies screened represent the total colonies present in the 1 ml of transformed bacteria obtained from each transfection. In experiments with two or three
replicate transfections, d represents the colonies in 2 or 3 ml, respectively.
Table 2. Analysis of accurate and inaccurate repair events
Cell line EcoRV-restricted plasmids EcoRI-restricted plasmids
Accuracya Sequence analysisb Accuracya Sequence analysisb
Nos
analyzed
Mean
deletion
size (bp)
Insertions MH Nos
analyzed
Mean
deletion
size (bp)
Insertions MH
Nalm-6 2% 23 169 61% 67% 22% 27 42 85% 25%
(4/180) (14/23) (6/9) (37/171) (23/27) (1/4)
N114P2 0% 18 371 28% 92% 4% 36 94 25% 81%
(0/130) (5/18) (12/13) (7/161) (9/36) (22/27)
P = 0.142 P = 0.099 P = 0.048 P = 0.264 P <0.0001 P = 0.202 P <0.0001 P = 0.052
1BR3neo 38% 42 572 17% 74% 20% 33 545 27% 75%
(72/191) (7/42) (26/35) (9/44) (9/33) (18/24)
180BRneo 9% 16 358 31% 73% 3% 16 430 19% 69%
(11/128) (5/16) (8/11) (1/29) (3/16) (9/13)
P = 0.001 P =0.126 P = 0.281 P >0.999 P = 0.044 P = 0.384 P = 0.726 P = 0.716
1BR3 30% 17 520 29% 92% 29% 14 289 21% 55%
(39/130) (5/17) (11/12) (26/91) (3/14) (6/11)
180BR 0%
(0/25)
7 152 29%
(2/7)
100%
(5/5)
ND ND ND ND ND
P <0.0001 P = 0.053 P >0.999 P >0.999
AHH1 36% 20 285 5% 68% 34% 23 320 9% 81%
(51/142) (1/20) (13/19) (56/164) (2/23) (17/21)
LB2304 0% 21 303 5% 55% 0% 14 202 14% 75%
(0/144) (1/21) (11/20) (0/95) (2/14) (9/12)
P <0.0001 P = 0.964 P >0.999 P >0.999 P <0.0001 P = 0.259 P = 0.625 P = 0.686
MH, microhomology; ND, not determined.
aPercentage of the total number of recominants in which the original restriction site was restored.
bSequence analysis of randomly selected independent inaccurate repair events.
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joining. In contrast, although N114P2 cells also express high
levels of TdT (data not shown), the junctions from
recombinants derived from N114P2 had signi®cantly fewer
insertions compared with those found in Nalm-6 (28 and 25%
for EcoRV and EcoRI, respectively). Additionally, these
insertions were frequently longer and had a lower GC content
compared with those observed in Nalm-6 cells (Fig. 2). These
observations provide suggestive evidence that a component of
the insertions in Nalm-6 cells is both TdT and DNA ligase IV
dependent.
Taken together, these results show that DNA ligase IV is
required for the majority (>90%) of end-joining events
observed in these pre-B cells. Furthermore, since LIG4 is
fully inactivated in the N114P2 cells, the residual rejoining
observed shows that end joining can also take place via a DNA
ligase IV-independent process. This alternative process(es) is
more ef®cient in carrying out cohesive end rejoining than
blunt end rejoining. Another striking feature of the processing
of DSBs in the absence of DNA ligase IV is a marked
decreased in the ®delity of end rejoining.
The frequency and ®delity of plasmid DNA end joining
in vivo are impaired in cells harboring hypomorphic
mutations in LIG4
Having established that the plasmid host cell end-joining assay
monitors a DNA ligase IV-dependent process, we next
examined several recently described human cell lines harbor-
ing hypomorphic mutations in LIG4. First, using the same
experimental strategy as described above, we examined an
SV40-transformed cell line, 180BRneo, that was derived from
a leukemia patient, who proved to have a mutation in LIG4.
The mutational change, a substitution of a histidine for an
arginine (R278H) in the active site motif, dramatically impairs
but does not abolish DNA ligase IV function (26). We
observed a modest but signi®cant decrease in end-joining
frequency (4.3-fold) of EcoRV-cut plasmids in 180BRneo
relative to 1BR3neo, a control SV40 immortalized line
(Table 3). A modest decrease in frequency was also observed
using EcoRI-cut plasmids (2.3-fold). However, due to the
variation in frequency between experiments, this difference is
not statistically signi®cant.
The ®delity of rejoining for both EcoRV- and EcoRI-cut
plasmids was signi®cantly lower in 180BRneo cells relative to
1BR3neo cells (Table 2). Sequencing of randomly chosen
inaccurately rejoined plasmids from these two lines indicates
that there was no appreciable difference in the size of deletions
nor in the occurrence of junctions with insertions or
microhomology.
Taken together, our results indicate that the hypomorphic
LIG4 mutation in 180BR cells confers only a modest impact
on the frequency of plasmid rejoining in 180BRneo cells
compared with the marked decrease found in cells with
inactivated LIG4. There was, however, a signi®cant decrease
in the accuracy of plasmid rejoining in 180BRneo cells. These
results suggest that there is suf®cient residual DNA ligase IV
activity in 180BRneo cells to enable plasmids to be rejoined,
albeit with impaired ®delity.
We have reported previously that the levels of NHEJ
proteins (Ku70, Ku80 and DNA-PKcs) are lower in primary
cells (1BR3 and 180BR) relative to transformed cells (1BRneo
and 180BRneo cells), possibly re¯ecting the faster growth rate
of transformed cells (30). We also observed lower levels of
DNA ligase IV in 180BR primary cells relative to 180BRneo
cells (data not shown). We therefore argued that if the
considerable rejoining capacity remaining in 180BRneo cells
represents residual activity due to higher levels of a mutant
protein, the defect might be less marked than in 180BR
primary cells. We therefore attempted to carry out the host cell
Figure 2. Nucleotide sequence analysis of the junctions of inaccurately
rejoined plasmids from Nalm-6 and N114P2 cells. Recombinants were
obtained with (A) EcoRV- or (B) EcoRI-linearized substrate. Letters in the
center indicate extra nucleotides. The number of nucleotides deleted from
each end is noted under del.
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end-joining assay using primary 180BR and control (1BR3)
®broblast cell lines. The primary cells have a markedly lower
transformation frequency than transformed lines, making the
analysis more restricted. The results in Tables 2 and 3
represent the compiled data from two experiments. Using
EcoRV-cut plasmids, there was a markedly decreased
(34-fold) end-joining frequency in 180BR versus 1BR3
cells. None of the 25 plasmids recovered from 180BR cells
was rejoined accurately, suggesting that the ®delity of
rejoining is also decreased since 30% of plasmids recovered
from 1BR3 cells were rejoined accurately. Sequence analysis
of a sample of these plasmids showed a small difference in
deletion size between 180BR and 1BR3 cells, which was not
statistically signi®cant considering the limited number of
deletions analyzed for 180BR cells and the range of deletion
sizes observed. Using EcoRI-linearized plasmids, we did not
recover any rejoined plasmids from 180BR cells despite a
rejoining frequency of 2±3% being observed in a control
primary ®broblast cell line and ef®cient recovery of circular
plasmids. Taken together, our ®ndings suggest that the
frequency and ®delity of end joining are strongly decreased
in 180BR relative to control primary cells and are more
marked than the defect seen in the transformed derivative.
Recently, we described additional patients with hypo-
morphic mutations in LIG4 (6). These patients, in contrast to
patient 180BR, have marked clinical phenotypes including
immunode®ciency, microcephaly and developmental delay,
and represent a new disorder called LIG4 syndrome (6). For
this study, we examined LB2304, a lymphoblastoid cell line
with very low levels of mutant DNA ligase IV protein (6). Due
to the low numbers of colonies recovered using both cut and
uncut plasmids, we were unable to estimate the frequency of
rejoining. However, a suf®cient number of plasmids were
recovered to analyze the accuracy of rejoining (Table 2). In
multiple experiments with a normal lymphoblastoid cell line
(AHH1), we observed an accuracy of rejoining of 34%
(EcoRI) and 36% (EcoRV) (Table 2) (27). In marked contrast,
no accurately rejoined junctions were observed in three
independent experiments with LB2304 cells using EcoRV-cut
plasmids and two experiments using EcoRI-cut plasmids
(Table 2). Sequence analysis of inaccurately rejoined plasmids
derived from LB2304 cells frequently revealed the recovery of
identical recombinants, a feature not observed with control
cells. These products were probably derived from the same
rejoining event and are indicative of a low end-joining
frequency. The sequences analyzed in Table 2 represent
independent recombinants. No marked or consistent changes
in deletion size were observed in LB2304 cells, nor in the use
of microhomology or the presence of insertions.
Thus, the LB2304 cell line, derived from a patient with
severe clinical features, is, like 180BR, very dramatically
impaired in the accuracy of plasmid end rejoining.
Cell extracts from LIG4 mutant cell lines are unable to
promote in vitro end joining
To analyze further the ability of LIG4 mutant cell lines to carry
out DNA end joining, we examined the capacity of cell-free
extracts to catalyze in vitro end joining, a previously described
assay that is dependent upon the known NHEJ components
(29). Linearized DNA substrates with 5¢-complementary
(SalI) ends were incubated with cell-free extracts, and the
end-joining products visualized by hybridization using a 32P-
labeled probe with homology to the substrate (Fig. 3A).
Extracts from control cell lines, AHH1, HSC93 and Nalm-6
(Fig. 3A, lanes 2, 3 and 6), were capable of converting
35±70% of the input substrate into multimeric products during
the 2 h incubation. In contrast, extracts derived from LIG4
mutant cell lines, LB2304 (Fig. 3A, lane 4) and N114P2
(Fig. 3A, lane 7), show no detectable multimeric product
formation. These results verify that the assay is dependent
upon DNA ligase IV±XRCC4 and that the low level of
residual activity in LB2304 cells is unable to promote DNA
end joining ef®ciently in this assay. The addition of
baculovirus-expressed wild-type DNA ligase IV±XRCC4
complex restored nearly normal levels of product formation
to both LB2304 and N114P2 cell extracts (Fig. 3A, lanes 5 and
8). In the absence of extract, the rejoining catalyzed by DNA
ligase IV±XRCC4 alone was negligible (Fig. 3A, lane 9). For
all cell extracts, a similar low level of recircularized product is
observed. Together, these results indicate that, although DNA
ligase IV-independent rejoining can occur, the predominant
end-joining activity in human cell extracts is dependent upon
DNA ligase IV.
Table 3. Frequency of end joining
Exp EcoRV-restricted plasmid EcoRI-restricted plasmid
1BRneo 180BRneo 1BRneo 180BRneo
Colonies %EJ Colonies %EJ Colonies %EJ Colonies %EJ
(cut/uncut) (cut/uncut) (cut/uncut) (cut/uncut)
1 15 000/103 000 14.6 38/1440 2.6 2920/138 400 2.1 92/9600 0.96
2 1075/25 500 4.2 119/12 200 0.98 20 800/528 800 3.9 142/29 600 0.48
3 7900/138 400 5.7 150/9600 1.6 17 500/103 000 17.0 63/1440 4.4
4 9020/181 600 5.0 40/1960 2.0 1750/25 500 6.9 780/12 220 6.4
5 32 000/528 800 6.0 354/29 600 1.2
Mean 7.0 6 3.8 1.6 6 0.6 P = 0.022 7.5 6 6.0 3.0 6 2.5 P = 0.268
EcoRV-restricted plasmid EcoRI-restricted plasmid
1BR3 180BR 1BR3 180BR
Colonies %EJ Colonies %EJ 1BR3/ Colonies %EJ Colonies %EJ 1BR3/
(cut/uncut) (cut/uncut) 180BR (cut/uncut) (cut/uncut) 180BR
1050/21 650 4.8 25/17 800 0.14 34.3 690/26 200 2.6 0/21 300 <0.004 >650
The results shown with 1BRneo and 180BRneo cells represent the values of 4±5 experiments. The mean and SD is given. The P-values represent the
signi®cance of the difference between the two sets calculated using the t-test.
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DNA ligase IV±XRCC4 is involved in the protection of
DNA ends
In the experiments described above, the similar recovery of
unrejoined plasmid and the absence of any smearing indicated
that there is not any extensive degradation of the input plasmid
DNA. However, since the in vitro end-joining reaction can
only promote precise end-to-end joining (29; data not shown),
loss of a few base pairs could potentially inhibit the reaction.
To examine end degradation, we performed similar experi-
ments using a 5¢-32P-end-labeled SalI-linearized plasmid
substrate (Fig. 3B). Unexpectedly, in LB2304 cell extracts, a
substantial loss of signal was observed (Fig. 3B, lane 4),
suggesting degradation of the terminal nucleotide(s). The use
of a 3¢-32P-end-labeled oligonucleotide (49mer) con®rmed
that the observed loss of signal was due to degradation and
indicated that nucleotide loss most frequently involves
between one and seven nucleotides (data not shown).
Degradation, however, is not inherent to the loss of DNA
ligase IV since N114P2 cell extracts do not display increased
levels of degradation (Fig. 3B, lane 9). Addition of the puri®ed
Ku heterodimer to LB2304 cell extracts did not overcome the
degradation (Fig. 3B, lane 5). Surprisingly, however, addition
of puri®ed DNA ligase IV±XRCC4 restored both the
end-joining activity of the LB2304 extract (appearance of
multimeric products) and the stability of the DNA ends
(signi®cantly increased signal from the unrejoined substrate)
(Fig. 3B, lane 6). Addition of DNA ligase IV±XRCC4 also
restored the end-joining activity of N114P2 cell extracts
(Fig. 3B, lane 10), consistent with the results described above
(Fig. 3A, lane 8). Together, these results suggest that, during
the DNA end-joining process, the DNA ligase IV±XRCC4
complex plays a role in end protection as well as in ligation.
To characterize further the end joining and end protection
functions of DNA ligase IV±XRCC4, we examined the impact
of DNA ligase IV±XRCC4 concentration. At low concentra-
tions of DNA ligase IV±XRCC4 (11 and 22 ng), very little, if
any, effect was observed on the stability of DNA ends in
LB2304 extracts (Fig. 3C, lanes 4 and 5). In contrast, these
same low concentrations of DNA ligase IV±XRCC4 restored
the end-joining activity (dimer formation) to N114P2 extracts
to ~40% of the level seen in Nalm-6 extracts (Fig. 3C,
compare lanes 9 and 11). An increase in the stability of DNA
ends and end joining in LB2304 extracts was only observed at
higher levels of DNA ligase IV±XRCC4 (90 and 180 ng).
These results indicate that in the LB2304 background, higher
concentrations of DNA ligase IV±XRCC4 are required to
prevent end degradation than are required for ligation.
Moreover, they suggest that DNA degradation is not simply
a consequence of lack of rejoining but rather that rejoining
cannot be seen if the ends are degraded. The relative levels of
ligation compared with end degradation will depend upon the
endogenous level of nuclease activity, which is likely to vary
between cell lines.
Figure 3. Involvement of DNA ligase IV in plasmid end joining in vitro.
(A) Protein extracts (40 mg) prepared from control lymphoblastoid cell
lines, AHH1, HSC93 and Nalm-6, the LIG4 syndrome cell line LB2304 and
the LIG4-null cell line N114P2 were incubated with SalI-linearized pSJ
DNA (20 ng) as described in Materials and Methods. Lanes 1 and 9, no
extract. Recombinant DNA ligase IV±XRCC4 (180 ng) was added where
shown. The reaction products were loaded on an agarose gel, blotted and
hybridized with a 32P-labeled probe that is homologous to pSJ. The
percentage total radioactivity in each lane converted into product (circular,
monomer, dimer, trimer, tetramer, etc.) is indicated. (B) End-joining
reactions were carried out as described in (A) except that 5¢-32P-end-labeled
SalI-linearized pSJ (20 ng) was utilized. Recombinant DNA ligase
IV±XRCC4 (180 ng) and Ku70/Ku86 (200 ng) were added where shown.
Product formation was analyzed by agarose gel electrophoresis followed by
autoradiography. (C) Effect of DNA ligase IV±XRCC4 protein
concentration on DNA end joining. Extracts (40 mg) prepared from control
lymphoblastoid cell lines, AHH1 and Nalm-6, the LIG4 syndrome cell
line, LB2304 and the LIG4-null cell line, N114P2 were incubated with 5¢-
32P-end-labeled SalI-linearized pSJ (20 ng). Various dilutions of
recombinant DNA ligase IV±XRCC4 were added as shown. Product
formation was analyzed by agarose gel electrophoresis followed by
autoradiography. The percentage total radioactivity in each lane converted
into product (circular, monomer, dimer, trimer, tetramer, etc.) is indicated.
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End protection by DNA ligase IV±XRCC4 is
independent of DNA ligation
To separate further the end-joining and end-protection func-
tions of the DNA ligase IV±XRCC4 complex, LB2304 cell
extracts were incubated with a non-ligatable DNA substrate in
both the presence and absence of DNA ligase IV±XRCC4
(Fig. 4). The substrate used in this experiment was generated
by the incorporation of a single nucleotide at the 3¢ end of a
SalI-linearized plasmid (Fig. 4 and Materials and Methods).
Since the in vitro end-joining assay can promote only simple
ligation events, this nucleotide insertion eliminates terminal
homology and prevents the majority of end-joining events in
normal cell extracts (Fig. 4, lanes 2 and 5). In the presence of
LB2304 cell extracts, as described previously, a signi®cant
reduction of monomer signal due to increased end degradation
is observed (Fig. 4, lane 3). Addition of puri®ed DNA ligase
IV±XRCC4 complex has no effect on the formation of end-
joining products, yet results in the restoration of monomer
signal to levels similar to normal cells (Fig. 4, lane 4). These
results indicate that the end protection observed in the
presence of DNA ligase IV±XRCC4 complex is independent
of DNA ligation.
DNA ligase IV±XRCC4 can protect against end
degradation by T7 exonuclease
To gain further evidence for a role of DNA ligase IV±XRCC4
in protecting DNA ends from degradation, we examined the
ability of in vitro expressed proteins to prevent degradation by
T7 exonuclease. Addition of 5 U of T7 exonuclease resulted in
signi®cant loss (93%) of the label from a 5¢-end-labeled DNA
substrate with cohesive ends (Fig. 5, top, compare lanes 1 and
2). Addition of Ku prevented this degradation, partially at low
concentrations and more signi®cantly at higher concentra-
tions. The low concentration of Ku results in 1±2 molecules
bound per DNA, and the higher concentration results in
multiple Ku molecules bound to the DNA (data not shown). In
the presence of DNA ligase IV±XRCC4, signi®cant ligation is
observed (Fig. 5, top, lanes 5 and 6). Taking the stability of the
end-labeled nucleotide to represent end protection (i.e.
estimating the label present in both ligated and non-ligated
substrate), DNA ligase IV±XRCC4 can also prevent end
degradation. The combined presence of DNA ligase
IV±XRCC4 and Ku inhibited ligation, a feature observed
previously (31), but enhanced the stability of the end label to a
level equivalent to an additive contribution of the separate
complexes (Fig. 5, top, lanes 7 and 8). Since the buffer
conditions required for ligation are similar to those required
for T7 exonuclease activity, we were unable to examine end
protection in the absence of ligation using a cohesive-ended
substrate. Therefore, to substantiate the separation of end
protection from ligation, we also employed a blunt-ended
substrate, which is a poor substrate for DNA ligase
IV±XRCC4 ligation (Fig. 5, bottom). Consistent with the
®ndings above, we observed that DNA ligase IV±XRCC4
provided end protection in these conditions in which, as
anticipated, no ligation was observed. Together, these results
support the notion that the presence of DNA ligase
IV±XRCC4 protects DNA ends from end degradation by T7
exonuclease.
Figure 4. End protection by DNA ligase IV±XRCC4 protein can occur in
the absence of DNA end joining. Protein extracts (40 mg) prepared from
control lymphoblastoid cell lines, AHH1 and Nalm-6, the LIG4 syndrome
cell line LB2304 and the LIG4-null cell line N114P2 were incubated with a
non-ligatable 5¢-32P-end-labeled substrate (20 ng). Recombinant DNA ligase
IV±XRCC4 (180 ng) was added where shown. Product formation was
analyzed by agarose gel electrophoresis followed by autoradiography.
Figure 5. Ku and DNA ligase IV±XRCC4 separately and in combination
can protect against T7 exonuclease digestion. T7 exonuclease (5 U) in the
absence or presence of Ku and/or DNA ligase IV±XRCC4, as indicated,
was incubated with an end-labeled substrate having cohesive ends (top) or
blunt ends (bottom), and the products were analyzed by electrophoresis and
autoradiography. The results shown are representive of three experiments
undertaken, and the percentage recovery of the label represents the mean of
the three experiments. Lane 1, control substrate; lane 2, substrate + 5 U of
T7 exonuclease; lanes 3±8, substrate with T7 exonuclease and Ku and/or
DNA ligase IV±XRCC4 as indicated.
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DISCUSSION
Although NHEJ represents the major DSB repair mechanism
in mammalian cells, little is known about its ef®ciency. Two
factors, the frequency and ®delity of rejoining, are important
parameters in the ef®ciency of repair. The frequency, repre-
senting the capacity of cells to rejoin the DSB, is likely to
correlate with survival. The ®delity represents the ability to
rejoin the break accurately and may in¯uence other end points
such as genomic stability and the onset of oncogenesis.
Using a LIG4-null human pre-B cell line, we show that the
absence of DNA ligase IV results in decreased frequency and
®delity of end joining in an in vivo plasmid assay. The
dramatic defect observed here contrasts with the extremely
mild defect seen using NHEJ-defective rodent cell lines
(15,16). One explanation is that rodent cells have higher levels
of an alternative end-joining pathway relative to human cells,
a feature also suggested from analysis of end joining using
cell-free extracts (29). However, residual activity with
decreased ®delity is observed in the ligase IV-null cell line,
demonstrating the existence of an error-prone LIG4-
independent end-joining process, a feature consistent with
the residual DSB rejoining activity observed using pulsed-
®eld gel electrophoresis (6,32). This rejoining activity
appears to be more pro®cient in rejoining cohesive-ended
relative to blunt-ended breaks. An error-prone DNA ligase IV-
independent rejoining mechanism has also been described in
Saccharomyces cerevisiae (7).
Analysis of lines with hypomorphic mutations in LIG4 also
demonstrate that DNA ligase IV has a profound impact on the
®delity of rejoining. Indeed, no accurately rejoined junctions
were recovered in our studies using 180BR primary cells or
LB2304 cells. With these two lines, the frequency of rejoining
was either not estimatable or very low. Thus, it is possible that
the residual rejoining, like that observed in the LIG4-null line,
occurs via an error-prone DNA ligase IV-independent mech-
anism. With 180BRneo cells, however, the frequency of
rejoining is only modestly impaired. Since 180BRneo cells
have higher levels of residual DNA ligase IV compared with
their primary counterpart, we suggest that the residual
rejoining results from residual ligase IV activity. Consistent
with this notion, we have shown that 180BRneo cells have
10±20% of wild-type DNA ligase IV activity (26). However,
under these conditions where the majority of rejoining occurs
via a DNA ligase IV-dependent mechanism, the ®delity of
rejoining is noticeably decreased. Thus, residual but impaired
DNA ligase IV activity can impact upon the ®delity of
rejoining. This raises the possibility that subtle alterations in
ligase IV activity that may not appreciably affect the
frequency of rejoining nonetheless may impair the ®delity.
These ®ndings with 180BRneo cells are consistent with results
obtained using a plasmid assay for V(D)J recombination
(6,30). Together, our ®ndings show that the plasmid-based
assay in human cells monitors the process of NHEJ, in contrast
to ®ndings obtained using rodent cells. Impaired DNA ligase
IV activity has as great or an even greater impact on the
®delity of rejoining as it does on the end-joining frequency.
Sequence analysis of the inaccurately rejoined junctions has
also provided insight into the events taking place at DNA
ends. No consistent change in deletion size was seen in the
DNA ligase IV-defective lines. Microhomology was observed
frequently in the inaccurately rejoined junctions, demonstrat-
ing that DNA ligase IV-independent rejoining can exploit
direct repeat sequences to aid rejoining. Another observation
is that, in contrast to the lymphoblastoid and ®broblast cell
lines examined in this study, the junctions derived from the
pre-B cell line, Nalm-6, displayed a signi®cant number of
insertions (76%). The characteristics of these insertions
coupled with high TdT expression suggest that they arise as
TdT insertions. We also ®nd that insertion events were slightly
more prevalent with the substrate containing a 3¢ extension
(EcoRI, 88%) than with the blunt-ended substrate (EcoRV,
61%), consistent with the reported end preference of TdT (33).
Together, these ®ndings suggest that TdT might participate in
the repair of restriction enzyme-generated DSBs as well as
those generated during V(D)J recombination. Furthermore, in
N114P2 cells, a signi®cantly lower frequency of insertions
(25%) is found, which do not have a marked TdT signature.
Since N114P2 cells also express high levels of TdT, this
suggests that TdT insertions require the presence of DNA
ligase IV. This dependence may re¯ect a requirement for
NHEJ factors in the recruitment of TdT, possibly through a
direct interaction. In line with this possibility, a direct
interaction between TdT and DNA ligase IV±XRCC4 has
been demonstrated recently in vitro, and TdT is stably
recruited to DNA only in the presence of both Ku and DNA
ligase IV±XRCC4 (34).
The N114P2 cell extracts also show a dramatic defect in
promoting end joining, demonstrating directly that the in vitro
assay is DNA ligase IV dependent and supporting previous
studies based on DNA ligase IV±XRCC4 immunodepletion
(29). Surprisingly, the LB2304 cells displayed pronounced
loss of the end-labeled terminal nucleotide of the substrate
(Fig. 3B), which represents the loss of around 1±7 nucleotides
(data not shown). This is not an inherent feature of loss of
DNA ligase IV since it is not observed in N114P2 cell extracts.
Increased end degradation with a wild-type lymphoblastoid
cell line has been observed previously using the same assay,
suggesting that it is attributable to high exonuclease activity
present in certain cellular backgrounds (29). Addition of DNA
ligase IV±XRCC4 complex to LB2304 extracts restored end-
joining activity and the stability of DNA ends. Higher
concentrations of DNA ligase IV±XRCC4 are required for
end protection than for ligation, and end protection is not
dependent upon ligation. Thus, end protection is not simply
the result of removing the DNA ends by ligation. We also
show that DNA ligase IV±XRCC4 can contribute to the
protection of ends from degradation by T7 exonuclease. This
effect was, again, not dependent upon ligation, demonstrated
by using a non-ligatable blunt-ended substrate or a cohesive-
ended substrate with high concentrations of Ku. The latter
causes inhibition of ligation, a feature observed previously by
ourselves and others (31). The inhibition of end degradation
was observed by the presence of DNA ligase IV±XRCC4
alone or was additive with Ku (67% recovery of label in the
presence of Ku and DNA ligase IV±XRCC4 versus 39%
recovery in the presence of Ku alone), a ®nding consistent
with previous reports that Ku helps to recruit DNA ligase
IV±XRCC4 to DNA (31).
Together, these results support the conclusion that DNA
ligase IV±XRCC4 can protect DNA ends from degradation in
a manner separable from and not a direct result of ligation.
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Using the recombinant proteins, we have con®rmed previous
®ndings that DNA ligase IV±XRCC4 has DNA-binding
activity observable by electrophoretic mobility shift assay
(EMSA) using both cohesive- and blunt-ended substrates (35;
data not shown). In this context, it is noteworthy that the
crystal structure studies of the Chlorella virus DNA ligase
provided direct evidence that the 3¢ OH of the ligase-AMP
directly contacts the PO4 of the nick, raising the possibility
that end protection may require adenylate complex formation
(36). Furthermore, XRCC4 is expressed at normal levels in
LB2304 cells; thus, XRCC4 alone is not suf®cient for end
protection. Further work is in progress to examine the basis
underlying end protection.
Our studies on plasmid rejoining in vivo demonstrate that
the presence of DNA ligase IV serves to promote accurate
rejoining. The observation that DNA ligase IV±XRCC4 can
prevent end degradation in vitro could potentially provide one
explanation for the in vivo ®ndings. However, slower DNA
ligation allowing increased time for degradation or the nature
of the alternative rejoining mechanism may also contribute to
the reduced ®delity observed in vivo. Intriguingly, the ®ndings
from the in vivo and in vitro studies are remarkably consistent.
First, under both conditions, higher levels of DNA ligase IV
appear to be required to prevent end degradation than are
required for ligation. Additionally, the in vitro studies
demonstrate that the end-protection function of DNA ligase
IV±XRCC4 protects only a small number of nucleotides at the
DNA end, which is consistent with the in vivo ®nding of
decreased accurate rejoining in LIG4 mutants but no overt
change in deletion size. Thus, although the overall level of
®delity observed in vivo may be in¯uenced by multiple factors
such as the nucleolytic capacity of the cells, the end-protection
capacity of DNA ligase IV should be included as a potential
determinant.
The ®delity of end joining is likely to be a major factor
in¯uencing cancer onset, and in this context it is noteworthy
that the 180BR patient, whilst not displaying any overt
immunode®ciency re¯ective of a decreased frequency of
V(D)J recombination, did develop leukemia, possibly re¯ect-
ing impaired ®delity. In conclusion, our ®ndings demonstrate
that DNA ligase IV is an important factor in¯uencing the
®delity of rejoining in human cells. The newly described
ability of DNA ligase IV to protect DNA ends from
nucleolytic degradation may be a factor in¯uencing the
®delity of rejoining.
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